MTOR and pulmonary arterial hypertension: For instance, pulmonary vascular remodeling in pulmonary arterial hypertension (PAH) is tied to dysregulated Wnt/β-catenin [4], HIPPO [5, 6], PI3K/Akt/mTOR [7–9], and activin signaling [10] pathways.